Pharmacological evidence that spinal α2C-and, to a lesser extent, α2A-adrenoceptors inhibit capsaicin-induced vasodilatation in the canine external carotid circulation

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 204-210

  Villalón, Carlos M ^a   Galicia Carreón, Jorge ^a   González Hernández, Abimael ^a   Marichal Cancino, Bruno A ^a   Manrique Maldonado, Guadalupe ^a   Centurión, David ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

B HT 933; BRL44408; CGRP; External carotid artery; JP 1302; Migraine

Indexed keywords

ACETYLCHOLINE; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA CALCITONIN GENE RELATED PEPTIDE; AZEPEXOLE; CAPSAICIN;

ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY DILATATION; ARTICLE; BINDING AFFINITY; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DOG; DRUG INFUSION; DRUG MECHANISM; EXTERNAL CAROTID ARTERY; EXTERNAL CAROTID CONDUCTANCE; HEART RATE; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ADRENERGIC ALPHA-2 RECEPTOR ANTAGONISTS; ANALGESICS, NON-NARCOTIC; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CAROTID ARTERY, EXTERNAL; CERVICAL VERTEBRAE; DISEASE MODELS, ANIMAL; DOGS; HEMODYNAMICS; INFUSIONS, SPINAL; MALE; MIGRAINE DISORDERS; PROTEIN ISOFORMS; RECEPTORS, ADRENERGIC, ALPHA-2; REGIONAL BLOOD FLOW; SPINAL CORD; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 84860494872     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.03.002     Document Type: Article

References (50)

1. Arulmani, U., Massenvandenbrink, A., Villalón, C.M., Saxena, P.R., 2004. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur. J. Pharmacol. 500, 315-330.
2. Bylund, D.B., 1992. Subtypes of α1- and α2-adrenergic receptors. FASEB J. 6, 832-839.
3. Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo Jr., R.R., Trendelenburg, U., 1994. InternationalUnion of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46, 121-136.
4. Caterina, M.J., Schumacher, M.A., Tominaga, M., Rosen, T.A., Levine, J.D., Julius, D., 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389, 816-824.
5. Chan, K.Y., Gupta, S., DeVries, R., Danser, A.H.J., Villalón, C.M., Muñoz-Islas, E., MaassenVanDenBrink, A., 2010. Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model. Br. J. Pharmacol. 160, 1316-1325.
6. Devedjian, J.C., Esclapez, F., Denis-Pouxviel, C., Paris, H., 1994. Further characterization of human α2-adrenoceptor subtypes: [3H]RX821002 binding and definition of additional selective drugs. Eur. J. Pharmacol. 252, 43-49.
7. Docherty, J.R., 1998. Subtypes of functional α1- and α2-adrenoceptors. Eur. J. Pharmacol. 361, 1-15.
8. Dux, M., Sántha, P., Jancsó, G., 2003. Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J. Physiol. 552, 859-867.
9. Goadsby, P.J., Edvinsson, L., 1993. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in man and cat. Ann. Neurol. 33, 48-56.
10. Goadsby, P.J., Lipton, R.B., Ferrarri, M.D., 2002. Migraine-current understanding and treatment. N. Engl. J. Med. 346, 257-270.
11. Graham, J.R., Wolff, H.G., 1938. Mechanisms of migraine headache and action of ergotamine tartrate. Arch. Neurol. Psychiatry 39, 737-763.
12. Gupta, S., Villalón, C.M., 2010. The relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT1B/1D and CGRP receptors. Pharmacol. Ther. 128, 170-190.
13. Holland, P.R., 2009. Modulation of trigeminovascular processing: novel insights into primary headache. Cephalalgia 3, 1-6.
14. Horais, K., Hruby, V., Rossi, S., Cizkova, D.,Meschter, C., Dorr, R., Yaksh, T.L., 2003. Effects of chronic intrathecal infusion of a α opioid agonist in dogs. Toxicol. Sci. 71, 263-275.
15. Humphrey, P.P., Feniuk, W., Marriott, A.S., Tanner, R.J., Jackson, M.R., Tucker, M.L., 1991. Preclinical studies on the anti-migraine drug, sumatriptan. Eur. Neurol. 31, 282-290.
16. Jasper, J.R., Lesnick, J.D., Chang, L.K., Yamanishi, S.S., Chang, T.K., Hsu, S.A., Daunt, D.A., Bonhaus, D.W., Eglen, R.M., 1998. Ligand efficacy and potency at recombinant α2-adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem. Pharmacol. 55, 1035-1043.
17. Jiménez-Mena, L.R., Gupta, S., Muñoz-Islas, E., Lozano-Cuenca, J., Sánchez-López, A., Centurión, D., Mehrotra, S., MaassenVanDenBrink, A., Villalón, C.M., 2006. Clonidine inhibits the canine external carotid vasodilatation to capsaicin by α2A/2C-adrenoceptors. Eur. J. Pharmacol. 543, 68-76.
18. Kapoor, K., Arulmani, U., Heiligers, J.P.C., Garrelds, I.M., Willems, E.W., Doods, H., Villalón, C.M., Saxena, P.R., 2003a. Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br. J. Pharmacol. 140, 329-338.
19. Kapoor, K., Arulmani, U., Heiligers, J.P.C., Willems, E.W., Doods, H., Villalón, C.M., 2003b. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. Eur. J. Pharmacol. 475, 69-77.
20. Kim, K.S., Yoo, H.Y., Park, K.S., Kim, J.K., Zhang, Y.H., Kim, S.J., 2012. Differential effects of acute hypoxia on the activation of TRPV1 by capsaicin and acidic pH. J. Physiol. Sci. 62, 93-103.
21. Kleinman, L.I., Radford, E.P., 1964. Ventilation standards for small mammals. J. Appl. Physiol. 19, 360-362.
22. Lida, H., Dohi, S., Tanahashi, T., Watanabe, Y., Takenaka, M., 1997. Spinal conduction block by intrathecal ketamine in dogs. Anesth. Analg. 85, 106-110.
23. Link, R.E., Desai, K., Hein, L., Stevens, M.E., Chruscinski, A., Bernstein, D., Barsh, G.S., Kobilka, B.K., 1996. Cardiovascular regulation in mice lacking α2-adrenergic receptor subtypes b and c. Science 273, 803-805.
24. MacMillan, L.B., Hein, L., Smith, M.S., Piascik, M.T., Limbird, L.E., 1996. Central hypotensive effects of the α2A-adrenergic receptor subtype. Science 273, 801-803.
25. McLennan, P.L., 1981. The hypothermic effect of clonidine and other imidazolidines in relation to their ability to enter the central nervous system inmice. Eur. J. Pharmacol. 69, 477-482.
26. Muñoz-Islas, E., Gupta, S., Jiménez-Mena, L.R., Lozano-Cuenca, J., Sánchez-López, A., Centurión, D.,Mehrotra, S.,MaassenVanDenBrink, A., Villalón, C.M., 2006. Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Br. J. Pharmacol. 149, 82-91.
27. Muñoz-Islas, E., Lozano-Cuenca, J., González- Hernández, A., Ramírez-Rosas, M.B., Sánchez-López, A., Centurión, D., Maassenvandenbrink, A., Villalón, C.M., 2009. Spinal sumatriptan inhibits capsaicin-induced canine external vasodilatation via 5-HT1B rather than 5-HT1D receptors. Eur. J. Pharmacol. 615, 133-138.
28. Olesen, J., Burstein, R., Ashina, M., Tfelt-Hansen, P., 2009. Origin of pain inmigraine: evidence for peripheral sensitisation. Lancet Neurol. 8, 679-690.
29. Potenza, M.A., De Salvatore, G., Montagnani, M., Serio, M., Mitolo-Chieppa, D., 1994. Vasodilatation induced by capsaicin in rat mesenteric vessels is probably independent of nitric oxide synthesis. Pharmacol. Res. 30, 253-261.
30. Sallinen, J., Höglund, I., Engström, M., Lehtimäki, J., Virtanen, R., Sirviö, J., Wurster, S., Savola, J.M., Haapalinna, A., 2007. Pharmacological characterization and CNS effects of a novel highly selective α2C-adrenoceptor antagonist JP-1302. Br. J. Pharmacol. 150, 391-402.
31. Saxena, P.R., De Vlaam-Schluter, G.M., 1974. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine-studies in an experimental model for migraine. Headache 13, 142-163.
32. Shevel, E., 2011a. The extracranial vascular theory of migraine-a great story confirmed by the facts. Headache 51, 409-417.
33. Shevel, E., 2011b. The extracranial vascular theory of migraine: an artificial controversy. J. Neural Transm. 118, 525-530.
34. Sprenger, T., Goadsby, P.J., 2009. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 7, 71.
35. Takeda, M., Ikeda, M., Tanimoto, T., Lipski, J., Matsumoto, S., 2002. Changes of the excitability of rat trigeminal root ganglion neurons evoked by α2-adrenoceptors. Neurosciences 115, 731-741.
36. Uhlén, S., Porter, A.C., Neubig, R.R., 1994. The novel α2-adrenergic radioligand [3H]- MK912 is α2C-selective among human α2A-, α2B- and α2C-adrenoceptors. J. Pharmacol. Exp. Ther. 271, 1558-1565.
37. Valdivia, L.F., Centurión, D., Arulmani, U., Saxena, P.R.,Villalón, C.M., 2004. 5-HT1B receptors, 2A/2C- and, to a lesser extent,1-adrenoceptorsmediate the external carotid vasoconstriction to ergotamine in vagosympathectomized dogs. Naunyn-Schmiedebergs Arch. Pharmacol. 370, 46-53.
38. Van Rossum, D., Hanisch, U.K., Quirion, R., 1997. Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci. Biobehav. Rev. 21, 649-678.
39. Van Zwieten, P.A., Thoolen, M.J., Timmermans, P.B., 1984. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. Hypertension 6 (5 Pt 2), II28-II33.
40. Villalón, C.M., Olesen, J., 2009. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol. Ther. 124, 309-323.
41. Villalón, C.M., Terrón, J.A., Hong, E., 1993. Role of 5-HT1-like receptors in the increase in external carotid blood flow induced by 5-hydroxytryptamine in the dog. Eur. J. Pharmacol. 240, 9-20.
42. Villalón, C.M., Ramírez-San Juan, E., Castillo, C., López-Muñoz, F.J., Terrón, J.A., 1995 Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs. Br. J. Pharmacol. 116, 2778-2784.
43. Villalón, C.M., De Vries, P., Rabelo, G., Centurión, D., Sánchez-López, A., Saxena, P.R., 1999. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and α2-adrenoceptors. Br. J. Pharmacol. 126, 585-594.
44. Villalón, C.M., Centurión, D., Valdivia, L.F., DeVries, P., Saxena, P.R., 2002. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proc. West. Pharmacol. Soc. 45, 199-210.
45. Villalón, C.M., Centurión, D., Willems, E.W., Arulmani, U., Saxena, P.R., Valdivia, L.F., 2004. 5-HT1B receptors and 2A/2C-adrenoceptors mediate external carotid vasoconstriction to dihydroergotamine. Eur. J. Pharmacol. 484, 287-290.
46. Villalón, C.M., Albarrán-Juárez, J.A., Lozano-Cuenca, J., Pertz, H.H., Görnemann, T., Centurión, D., 2008. Pharmacological profile of the clonidine-induced inhibition of vasodepressor sensory outflow in pithed rats: correlation with α2A/2C-adrenoceptors. Br. J. Pharmacol. 154, 51-59.
47. Willems, E.W., Valdivia, L.F., Ramírez-San Juan, E., Saxena, P.R., Villalón, C.M., 2001a. Pharmacological identification of the major subtypes of adrenoceptors involved in the canine external carotid vasoconstrictor effects of adrenaline and noradrenaline. Life Sci. 69, 143-153.
48. Willems, E.W., Valdivia, L.F., Saxena, P.R., Villalón, C.M., 2001b. Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs. Naunyn-Schmiedebergs Arch. Pharmacol. 364, 27-32.
49. Yaksh, T.L., Horais, K.A., Tozier, N., Rathbun, M., Richter, P., Rossi, S., Grafe, M., Tong, C., Meschter, C., Cline, J.M., Eisenach, J., 2004. Intrathecal ketorolac in dogs and rats. Toxicol. Sci. 80, 322-334.
50. Zhang, K.-M.,Wang, X.-M., Peterson, A.M., Chen, W.-Y., Mokha, S.S., 1998. α2-adrenoceptors modulate NMDA-evoked responses of neurons in superficial and deeper dorsal horn of the medulla. J. Neurophysiol. 80, 2210-2214.